Showing results (31-40 of 262) with videos related to
Sort By:
Pageof 27
The American Journal of Managed Care|September 3, 2014
Balancing therapeutic safety and efficacy to improve clinical and economic outcomes in schizophrenia: exploring the treatment landscapeDaniel C JavittCurrent Opinion in Investigational Drugs (London, England : 2000)|August 21, 2002
Glycine modulators in schizophreniaDaniel C JavittAnnual Review of Clinical Psychology|March 31, 2009
When doors of perception close: bottom-up models of disrupted cognition in schizophreniaDaniel C JavittAnnals of the New York Academy of Sciences|February 28, 2015
Neurophysiological models for new treatment development in schizophrenia: early sensory approachesDaniel C JavittCurrent Topics in Behavioral Neurosciences|April 1, 2025
Disturbances in Auditory and Visual Perceptual Function in Schizophrenia: Patterns, Causes, and ConsequencesDaniel C JavittSchizophrenia Research. Cognition|November 9, 2017
Meeting overview: Sensory perception and schizophrenia, Lausanne, Switzerland June 31-July 1, 2014Daniel C JavittInternational Review of Neurobiology|March 14, 2007
Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactionsDaniel C JavittAnnual Review of Pharmacology and Toxicology|September 23, 2022
Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to TreatmentDaniel C JavittCurrent Opinion in Drug Discovery & Development|June 30, 2009
Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modificationDaniel C JavittThe Israel Journal of Psychiatry and Related Sciences|August 6, 2010
Glutamatergic theories of schizophreniaDaniel C JavittPageof 27